Advertisement

Topics

Drugs approved in Scotland for bladder and skin cancers

05:00 EST 15 Feb 2018 | Cancer Research UK

News report

Two new cancer drugs have been approved for use on the NHS in Scotland. 

Pembrolizumab (Keytruda) was approved for advanced bladder cancer, and Ameluz was approved to treat a type of skin cancer

"This decision offers another treatment option for some patients with this devastating disease.” – Gregor McNie, Cancer Research UK

Gregor McNie, Cancer Research UK’s head of external affairs in Scotland, hailed the move as fantastic news. 

The Scottish Medicines Consortium (SMC) approved pembrolizumab, a type of immunotherapy, after consideration by its patient and clinician engagement process. 

It will be available for patients who have already been treated with chemotherapy for urothelial cancer, the most common type of bladder cancer, that is advanced or has spread to other parts of the body.

Studies showed that pembrolizumab improved survival by around 3 months and has fewer side effects than standard treatment.

How does pembrolizumab work?

Pembrolizumab is a type of immunotherapy that stimulates the body’s immune system to fight cancer cells, and this decision offers another treatment option for some patients with this devastating disease,” said McNie. 

The drug blocks an interaction between two molecules, one on the cancer cell and one on specialised immune cells. 

This releases the brakes on the immune cells and boosts their cancer-fighting ability. 

Around 830 patients are diagnosed with bladder cancer in Scotland every year.

“We’re pleased that SMC and the drug company worked together to make it routinely available to these patients in Scotland,” added McNie.

SMC chairman Dr Alan MacDonald said the drug will help provide patients with valuable additional months with their families.

Ameluz (5-aminolaevulinic acid hydrochloride) was approved to treat a type of early stage skin cancer called basal cell carcinoma, in cases where surgery is unsuitable.

Dr McDonald said that for those patients, Amelus offers a treatment option with a lower risk of scarring.

 

Read more

Original Article: Drugs approved in Scotland for bladder and skin cancers

NEXT ARTICLE

More From BioPortfolio on "Drugs approved in Scotland for bladder and skin cancers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bladder Cancer
Non-invasive bladder cancer is a cancer that is only in the inner lining of the bladder. Invasive bladder cancer is cancer that has spread into the deeper walls of the bladder. When the cancer has spread outside the bladder to other parts of the body, th...

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...